Hostname: page-component-848d4c4894-cjp7w Total loading time: 0 Render date: 2024-06-18T14:18:06.486Z Has data issue: false hasContentIssue false
  • English
  • Français

Being naughty about NICE? Questioning the methods used to maximize health gains from NHS resources

Published online by Cambridge University Press:  01 April 2007

STEPHEN BIRCH  and
AMIRAM GAFNI
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Reply
Information
Health Economics, Policy and Law , Volume 2 , Issue 2 , April 2007 , pp. 217 - 221
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Barrett, A., Roques, T., Small, M., and Smith, R. (2006), How much will Herceptin really cost?, British Medical Journal, 333: 1118–1120.CrossRefGoogle ScholarPubMed
Birch, S. and Donaldson, C. (1987), Applications of cost–benefit analysis to health care: departures from welfare economic theory, Journal of Health Economics, 6: 61–72.CrossRefGoogle ScholarPubMed
Birch, S. and Gafni, A. (1992), Cost-effectiveness/utility analyses: do current decision rules lead us to where we want to be?, Journal of Health Economics, 11: 279–296.CrossRefGoogle ScholarPubMed
Birch, S. and Gafni, A. (2006a), The biggest bang for the buck or bigger bucks for the bang: the fallacy of the cost-effectiveness threshold, Journal of Health Services Research and Policy, 11: 46–51.Google Scholar
Birch, S. and Gafni, A. (2006b), Information created to evade reality (ICER): things we should not look to for answers, Pharmcoeconomics, 24: 1121–1131.CrossRefGoogle Scholar
Cookson, R., McDaid, D., and Maynard, A. (2001), Wrong SIGN, NICE mess: Is national guidance distorting allocation of resources?, British Medical Journal, 323: 743–745.CrossRefGoogle ScholarPubMed
Drummond, M. (1980), Principles of Economic Appraisal in Health Care, Oxford: Oxford University Press.Google Scholar
Evans, R. (1984), Strained Mercy, Toronto: Butterworths.Google Scholar
Gafni, A. and Birch, S. (2003a), Inclusion of drugs in provincial benefit programs: should “reasonable decisions” lead to uncontrolled growth in expenditures?, Canadian Medical Association Journal, 168: 849–851.Google ScholarPubMed
Gafni, A. and Birch, S. (2003b), NICE methodological guidelines and decision-making in the NHS, Pharmacoeconomics, 21: 149–157.CrossRefGoogle Scholar
Gafni, A. and Birch, S. (2006), Incremental cost effectiveness ratios (ICERs): the silence of the lambda, Social Science and Medicine, 62: 2091–2100.CrossRefGoogle ScholarPubMed
Gold, M., Siegel, J., Russell, L., and Weinstein, M. (1996), Cost-Effectiveness in Health and Medicine, New York: Oxford University Press.CrossRefGoogle ScholarPubMed
Sendi, P., Gafni, A., and Birch, S. (2002), Opportunity costs and uncertainty in the economic evaluation of health care interventions, Health Economics, 11: 23–32.Google Scholar
Shipman, S., Lurie, J., and Goodman, D. (2004), The general pediatrician: projecting future workforce supply and requirements, Pediatrics, 113: 435–442.CrossRefGoogle ScholarPubMed